Aurinia Pharmaceuticals Inc. (AUPH) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Aurinia Pharmaceuticals Inc. (AUPH) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$99.89 MLiabilities$177.40 MCurrent assets$541.32 MAssets$792.26 MNon-current liabilities$77.51 MEquity$614.86 MGross equity(calculated)$1.19 BNon-current assets$250.94 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term investmentsCash, cash equivalents and restricted cashInventoryAccounts receivable, netPrepaid expenses and depositsOther current assetsDeferred tax assets, netFinance right-of-use lease assetsIntangible assets, netProperty and equipment, netOperating right-of-use lease assetsOther noncurrent assetsAccrued expensesFinance lease liabilities, current portionDeferred revenueOther current liabilitiesAccounts payableOperating lease liabilities, current portionFinance lease liabilities, less current portionDeferred tax benefitsDeferred revenue, less current portionOperating lease liabilities, less current portionOther noncurrent liabilitiesCommon shares — no par value, Unlimited shares authorized, 132,907 and 132,323 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyAdditional paid-in capitalCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive lossAccrued expensesAccrued expenses$64.11 MFinance lease liabilities, current portionFinance lease liabilities, current portion$16.48 MCurrent liabilitiesCurrent liabilities$99.89 MDeferred revenueDeferred revenue$10.59 MOther current liabilitiesOther current liabilities$5.27 MLiabilitiesLiabilities$177.40 MAccounts payableAccounts payable$1.74 MCurrent assetsCurrent assets$541.32 MShort-term investmentsShort-term investments$263.29 MOperating lease liabilities, current portionOperating lease liabilities, current portion$1.71 MFinance lease liabilities, less current portionFinance lease liabilities, less current portion$43.94 MCash, cash equivalents and restricted cashCash, cash equivalents and restricted cash$179.83 MAssetsAssets$792.26 MNon-current liabilitiesNon-current liabilities$77.51 MDeferred tax benefitsDeferred tax benefits$23.13 MInventoryInventory$45.15 MDeferred revenue, less current portionDeferred revenue, less current portion$7.48 MAccounts receivable, netAccounts receivable, net$41.14 MEquityEquity$614.86 MOperating lease liabilities, less current portionOperating lease liabilities, less current portion$2.01 MPrepaid expenses and depositsPrepaid expenses and deposits$10.53 MGross equity (calculated)Gross equity(calculated)$1.19 BOther noncurrent liabilitiesOther noncurrent liabilities$945.00 KOther current assetsOther current assets$1.38 MDeferred tax assets, netDeferred tax assets, net$178.94 MNon-current assetsNon-current assets$250.94 MFinance right-of-use lease assetsFinance right-of-use lease assets$65.15 MIntangible assets, netIntangible assets, net$3.38 MCommon shares — no par value, Unlimited shares authorized, 132,907 and 132,323 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyCommon shares — no par value,Unlimited shares authorized$1.12 BProperty and equipment, netProperty and equipment, net$1.86 MOperating right-of-use lease assetsOperating right-of-use lease assets$1.52 MOther noncurrent assetsOther noncurrent assets$93.00 KAdditional paid-in capitalAdditional paid-in capital$76.19 MAccumulated deficitAccumulated deficit−$577.60 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$977.00 K
Chart details

Aurinia Pharmaceuticals Inc. (AUPH) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
792,262,000 US dollars
Current assets
541,324,000 US dollars
Non-current assets
250,938,000 US dollars
Liabilities
177,398,000 US dollars
Current liabilities
99,893,000 US dollars
Non-current liabilities
77,505,000 US dollars
Equity
614,864,000 US dollars
Short-term investments
263,291,000 US dollars
Cash, cash equivalents and restricted cash
179,832,000 US dollars
Inventory
45,151,000 US dollars
Accounts receivable, net
41,138,000 US dollars
Prepaid expenses and deposits
10,531,000 US dollars
Other current assets
1,381,000 US dollars
Deferred tax assets, net
178,935,000 US dollars
Finance right-of-use lease assets
65,152,000 US dollars
Intangible assets, net
3,378,000 US dollars
Property and equipment, net
1,862,000 US dollars
Operating right-of-use lease assets
1,518,000 US dollars
Other noncurrent assets
93,000 US dollars
Accrued expenses
64,112,000 US dollars
Finance lease liabilities, current portion
16,479,000 US dollars
Deferred revenue
10,593,000 US dollars
Other current liabilities
5,269,000 US dollars
Accounts payable
1,735,000 US dollars
Operating lease liabilities, current portion
1,705,000 US dollars
Finance lease liabilities, less current portion
43,943,000 US dollars
Deferred tax benefits
23,128,000 US dollars
Deferred revenue, less current portion
7,480,000 US dollars
Operating lease liabilities, less current portion
2,009,000 US dollars
Other noncurrent liabilities
945,000 US dollars
Common shares — no par value, Unlimited shares authorized, 132,907 and 132,323 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
1,117,248,000 US dollars
Additional paid-in capital
76,192,000 US dollars
Accumulated deficit
negative 577,599,000 US dollars
Accumulated other comprehensive loss
negative 977,000 US dollars
Gross equity (calculated)
1,193,440,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Aurinia Pharmaceuticals Inc. (AUPH) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!